About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Hemoglobin Aalborg Causing Low Oxygen Saturation in a Child

mirtazapine and alcohol death

mirtazapine sleep read here
Benjamin Acheampong1, Melanie Chihak1,2, Vilmarie Rodriguez1,2
1Department of Pediatrics and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota;
2Division of Pediatric Hematology and Oncology, Mayo Clinic, Rochester, Minnesota 55904, USA.
Corresponding Author:
Dr. Vilmarie Rodriguez
Email: rodriguez.vilmarie@mayo.edu
Received: 18-JAN-2016 Accepted: 26-APR-2016 Published Online: 10-JUN-2016
DOI: http://dx.doi.org/10.17659/01.2016.0062
Abstract
Patients with inherited low oxygen affinity hemoglobin variants such as hemoglobin Aalborg could have low oxygen saturations despite normal oxygen delivery to tissues. Timely and correct diagnosis could help clinicians to avoid unnecessary investigations and spare patients unnecessary cost and anxiety. 
Keywords : Abnormal Hemoglobins, Hemoglobinopathies, Hemoglobin Aalborg, Humans, Oxygen.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports
Last updated on Jan 02, 2025